Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VSJ-110 in Dry Eye
NCT06296966Phase 2Recruiting
- Sponsor
- Vanda Pharmaceuticals Inc.
- Start
- Feb 2024
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of VSJ-110 in dry eye syndrome (DED), sponsored by Vanda Pharmaceuticals Inc.. Started Feb 2024; status: recruiting.
02
Drugs
VSJ-110
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT06296966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06296966.